MedTrace Logo

Validation of an Algorithm for the Diagnosis of Sarcopenic Obesity

NCT06815978 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2025-02-10

No results posted yet for this study

Summary

The proposed research project aims to investigate sarcopenic obesity (SO), a condition characterized by the combination of high body fat and low skeletal muscle mass, with a focus on muscle function. SO has been defined according to the ESPEN-EASO algorithm, and this study aims to evaluate its validity, exploring associations with circulating biomarkers and functional outcomes. By enrolling 75 subjects with SO and a control sample of 75 subjects with non-sarcopenic obesity, the primary objective of this study is to examine the consistency of the proposed diagnostic criteria with respect to circulating biomarkers and functional outcomes. Secondary objectives include the assessment of additional variables and the detailed profiling of SO subjects through questionnaires and multidimensional tests. The ethical aspect of the present study will be guaranteed through written informed consent and protection of privacy, respecting international regulatory standards. The investigators believe that this work provides significant contributions to the understanding of sarcopenic obesity and to the validation of diagnostic criteria, with possible implications for public health. The investigators are available for further clarifications and approvals required by the Ethics Committee.

Conditions

  • Sarcopenic Obesity

Interventions

DIAGNOSTIC_TEST

DXA

Dual energy X-ray absorptiometry

DIAGNOSTIC_TEST

ultrasonography

ultrasonography

DIAGNOSTIC_TEST

indirect calorimetry

indirect calorimetry

DIAGNOSTIC_TEST

MRI/ MRS (Magnetic Resonance Imaging /Magnetic Resonance Spectroscopy)

MRI/ MRS (Magnetic Resonance Imaging /Magnetic Resonance Spectroscopy)

DIAGNOSTIC_TEST

bioimpedentiometry

bioimpedentiometry

Sponsors & Collaborators

  • ministero della ricerca e dell'università

    collaborator UNKNOWN

  • Elisa Giannetta

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-05-24
Primary Completion
2027-03-01
Completion
2027-03-01

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06815978 on ClinicalTrials.gov